Hydrochloric Acid

Hydrochloric Acid

SCHEMBL8527191

C=Cc1ccc(S(=O)(=O)O)cc1.Cl

nearest known ligand 0.95

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 known ✓ O43613 1/20 0.35
HCRTR2 known ✓ O43614 1/20 0.35
HDAC8 known ✓ Q9BY41 1/20 0.33
CA2 known ✓ P00918 1/20 0.32
TDP1 Q9NUW8 3/20 0.95
ALDH1A1 P00352 8/20 0.50
LMNA P02545 3/20 0.50
TSHR P16473 5/20 0.48
NT5E P21589 1/20 0.48
SMN1; SMN2 Q16637 3/20 0.46
POLB P06746 1/20 0.41
CYP2D6 P10635 1/20 0.41
HSD17B10 Q99714 4/20 0.38
MAPT P10636 2/20 0.38
HTT P42858 2/20 0.38
NPC1 O15118 1/20 0.38
TP53 P04637 1/20 0.38
XBP1 P17861 1/20 0.38
MAPK1 P28482 1/20 0.38
RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4196689 0.98 TDP1 (0.91) TDP1ALDH1A1LMNATSHRNT5E
SCHEMBL31126649 0.98 TDP1 (1.00) TDP1ALDH1A1LMNATSHRNT5E
SCHEMBL452529 0.98 TDP1 (1.00) TDP1ALDH1A1LMNATSHRNT5E
SCHEMBL25711 0.98 TDP1 (1.00) TDP1ALDH1A1LMNATSHRNT5E
SCHEMBL331672 0.95 TDP1 (0.95) TDP1ALDH1A1LMNATSHRNT5E
Ammonia Solution, Strong SCHEMBL814454 0.95 TDP1 (0.95) TDP1ALDH1A1LMNATSHRNT5E
SCHEMBL5621481 0.95 TDP1 (0.95) TDP1ALDH1A1LMNATSHRNT5E
SCHEMBL17476641 0.95 TDP1 (0.95) TDP1ALDH1A1LMNATSHRNT5E
SCHEMBL2198423 0.95 TDP1 (0.95) TDP1ALDH1A1LMNATSHRNT5E
SCHEMBL813503 0.95 TDP1 (0.95) TDP1ALDH1A1LMNATSHRNT5E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024070672-A1 RESIST COMPOSITION AND METHOD FOR FORMING RESIST PATTERN 日本ゼオン株式会社 2024-04-04 WO disclosed
WO-2023189969-A1 RESIST COMPOSITION AND METHOD FOR FORMING RESIST PATTERN 日本ゼオン株式会社 2023-10-05 WO disclosed
CN-107849183-B Vinyl ether-vinyl ester copolymers 丸善石油化学株式会社 2022-04-26 CN disclosed
EP-3296333-B1 ALKENYL ETHER-VINYL ESTER COPOLYMER MARUZEN PETROCHEM CO LTD (JP) 2020-09-02 EP disclosed
US-10570232-B2 Alkenyl ether-vinyl ester copolymer MARUZEN PETROCHEMICAL CO., LTD. (JP) 2020-02-25 US disclosed
CN-109666120-A A kind of energy-absorbing method based on hydridization dynamic aggregation object 翁秋梅 2019-04-23 CN disclosed
US-20180155477-A1 ALKENYL ETHER-VINYL ESTER COPOLYMER MARUZEN PETROCHEMICAL CO., LTD. (JP) 2018-06-07 US disclosed
CN-105693566-B For the novel crosslinker for preparing the new isolated proton conducting polymer family for electrochemical device and the polymer 巴莱诺斯清洁能源控股公司 2018-04-03 CN disclosed
EP-3296333-A1 ALKENYL ETHER-VINYL ESTER COPOLYMER Maruzen Petrochemical Co., Ltd. (JP) 2018-03-21 EP disclosed
CN-103547534-B A method for improving rheological properties of mineral slurry 凯米罗总公司 2017-05-03 CN disclosed
US-9170514-B2 Polymerizable monomer, polymeric compound, charge control agent containing the polymeric compound, and developer bearing member and toner which contain the charge control agent CANON KABUSHIKI KAISHA (JP) 2015-10-27 US disclosed
EP-2691423-A1 POLYMERIZABLE MONOMER, POLYMERIC COMPOUND, CHARGE CONTROL AGENT CONTAINING THE POLYMERIC COMPOUND, AND DEVELOPER BEARING MEMBER AND TONER WHICH CONTAIN THE CHARGE CONTROL AGENT Canon Kabushiki Kaisha (JP) 2014-02-05 EP disclosed
US-20140011129-A1 POLYMERIZABLE MONOMER, POLYMERIC COMPOUND, CHARGE CONTROL AGENT CONTAINING THE POLYMERIC COMPOUND, AND DEVELOPER BEARING MEMBER AND TONER WHICH CONTAIN THE CHARGE CONTROL AGENT CANON KABUSHIKI KAISHA (JP) 2014-01-09 US disclosed
CN-1934500-B Antireflective film containing sulfur atom NISSAN CHEMICAL IND LTD 2013-03-13 CN disclosed
WO-2012133871-A1 POLYMERIZABLE MONOMER, POLYMERIC COMPOUND, CHARGE CONTROL AGENT CONTAINING THE POLYMERIC COMPOUND, AND DEVELOPER BEARING MEMBER AND TONER WHICH CONTAIN THE CHARGE CONTROL AGENT CANON KABUSHIKI KAISHA (JP) 2012-10-04 WO disclosed
CN-101040221-B Composition for forming bottom anti-reflective coating containing aromatic sulfonic acid ester compound and light photoacid-generating agent NISSAN CHEMICAL IND LTD 2010-06-16 CN disclosed
CN-101390244-A Liquid material for electrochemical cells UNIV NORTH CAROLINA (US) 2009-03-18 CN disclosed
CN-101040221-A Composition for forming bottom anti-reflective coating containing aromatic sulfonic acid ester compound and light photoacid-generating agent NISSAN CHEMICAL IND LTD (JP) 2007-09-19 CN disclosed
CN-1934500-A Antireflective film containing sulfur atom NISSAN CHEMICAL IND LTD (JP) 2007-03-21 CN disclosed
US-5807942-A ADDITION POLYMERIZABLE MONOMER UNIT IS ATTACHED TO ENZYME, ANTIBODY, ETC. AND RESULTING COMPOUND IS POLYMERIZED THROUGH DOUBLE BOND WITH ANOTHER MODIFIED ENZYME OR ANTIBODY OR WITH A MONOMER SUCH AS METHACRYLAMIDE, USED IN IMMUNOASSAY NOF CORPORATION (JP) 1998-09-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140011129-A1 POLYMERIZABLE MONOMER, POLYMERIC COMPOUND, CHARGE CONTROL AGENT CONTAINING THE POLYMERIC COMPOUND, AND DEVELOPER BEARING MEMBER AND TONER WHICH CONTAIN THE CHARGE CONTROL AGENT ASH2L, SMARCC1, SMARCC2 HCRTR1 420/4885HCRTR2 673/4885HDAC8 1118/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.